Answers are grounded in this paper and cite their sources.
Retrospective study identifies autoantibodies predicting interstitial lung disease in autoimmune disease patients, highlighting their role as biomarkers.
Anti-Ro52, together with age and anti-MDA5, was identified as a significant predictor of ILD in IIM patients. This study highlights the potential of autoantibodies as biomarkers for early detection and management of ILD in AID patients.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: